Catheter Ablation and Rate Control of Atrial Fibrillation in Patients With Heart Failure
NCT ID: NCT02846922
Last Updated: 2023-07-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
394 participants
OBSERVATIONAL
2016-08-31
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Ablation for Atrial Fibrillation
NCT04398979
Catheter Ablation Versus Medical Rate Control for Atrial Fibrillation in Patients With Heart Failure
NCT00878384
Efficacy and Safety Study of Catheter Ablation for Atrial Fibrillation
NCT01113294
Complex Arrhythmia Registry
NCT07024927
CAB Versus Medical Therapy in Patients With AF and HF With Different EF Categories
NCT05364866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
catheter ablation group
atrial fibrillation patients with heart failure who received catheter ablation for rhythm control
No interventions assigned to this group
rate control group
atrial fibrillation patients with heart failure who received pharmacological approaches for rate control
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* documented atrial fibrillation
* New York Heart Association Ⅱ-Ⅳ or left ventricular ejection fraction \<50%
Exclusion Criteria
* previous ablation
* any contraindication to catheter ablation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Nanjing Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jin Geng
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jin Geng, MD
Role: PRINCIPAL_INVESTIGATOR
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Bingjian Wang, MD
Role: STUDY_CHAIR
Huai'an First People's Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Drum Tower Hospital
Nanjing, Jiangsu, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20160020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.